These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25712343)

  • 21. Characterization and validation of potential therapeutic targets based on the molecular signature of patient-derived xenografts in gastric cancer.
    Chen Z; Huang W; Tian T; Zang W; Wang J; Liu Z; Li Z; Lai Y; Jiang Z; Gao J; Shen L
    J Hematol Oncol; 2018 Feb; 11(1):20. PubMed ID: 29433585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient-derived xenografts undergo mouse-specific tumor evolution.
    Ben-David U; Ha G; Tseng YY; Greenwald NF; Oh C; Shih J; McFarland JM; Wong B; Boehm JS; Beroukhim R; Golub TR
    Nat Genet; 2017 Nov; 49(11):1567-1575. PubMed ID: 28991255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models.
    Prasetyanti PR; van Hooff SR; van Herwaarden T; de Vries N; Kalloe K; Rodermond H; van Leersum R; de Jong JH; Franitza M; Nürnberg P; Todaro M; Stassi G; Medema JP
    Int J Cancer; 2019 Jan; 144(2):366-371. PubMed ID: 30151914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment of a patient-derived intrahepatic cholangiocarcinoma xenograft model with KRAS mutation.
    Cavalloni G; Peraldo-Neia C; Sassi F; Chiorino G; Sarotto I; Aglietta M; Leone F
    BMC Cancer; 2016 Feb; 16():90. PubMed ID: 26868125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer.
    Hao C; Wang L; Peng S; Cao M; Li H; Hu J; Huang X; Liu W; Zhang H; Wu S; Pataer A; Heymach JV; Eterovic AK; Zhang Q; Shaw KR; Chen K; Futreal A; Wang M; Hofstetter W; Mehran R; Rice D; Roth JA; Sepesi B; Swisher SG; Vaporciyan A; Walsh GL; Johnson FM; Fang B
    Cancer Lett; 2015 Feb; 357(1):179-185. PubMed ID: 25444907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishing a cryopreservation protocol for patient-derived xenografts of prostate cancer.
    Porter LH; Lawrence MG; Wang H; Clark AK; Bakshi A; Obinata D; Goode D; Papargiris M; Mural ; Clouston D; Ryan A; Norden S; Corey E; Nelson PS; Isaacs JT; Grummet J; Kourambas J; Sandhu S; Murphy DG; Pook D; Frydenberg M; Taylor RA; Risbridger GP
    Prostate; 2019 Aug; 79(11):1326-1337. PubMed ID: 31212368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian and cervical cancer patient derived xenografts: The past, present, and future.
    Boone JD; Dobbin ZC; Straughn JM; Buchsbaum DJ
    Gynecol Oncol; 2015 Aug; 138(2):486-91. PubMed ID: 26026736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma.
    Landuzzi L; Manara MC; Lollini PL; Scotlandi K
    Cells; 2021 Feb; 10(2):. PubMed ID: 33671173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of Personalized Therapeutic Strategies by Targeting Actionable Vulnerabilities in Metastatic and Chemotherapy-Resistant Breast Cancer PDXs.
    Punzi S; Meliksetian M; Riva L; Marocchi F; Pruneri G; Criscitiello C; Orsi F; Spaggiari L; Casiraghi M; Della Vigna P; Luzi L; Curigliano G; Pelicci PG; Lanfrancone L
    Cells; 2019 Jun; 8(6):. PubMed ID: 31216647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corruption of neuroblastoma patient derived xenografts with human T cell lymphoma.
    Williams AP; Stewart JE; Stafman LL; Aye JM; Mroczek-Musulman E; Ren C; Yoon K; Whelan K; Beierle EA
    J Pediatr Surg; 2019 Oct; 54(10):2117-2119. PubMed ID: 30391152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. pathTiMEx: Joint Inference of Mutually Exclusive Cancer Pathways and Their Progression Dynamics.
    Cristea S; Kuipers J; Beerenwinkel N
    J Comput Biol; 2017 Jun; 24(6):603-615. PubMed ID: 27936934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic Validation of Endometrial Cancer Patient-Derived Xenograft Models as a Preclinical Tool.
    Villafranca-Magdalena B; Masferrer-Ferragutcasas C; Lopez-Gil C; Coll-de la Rubia E; Rebull M; Parra G; García Á; Reques A; Cabrera S; Colas E; Gil-Moreno A; Moiola CP
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel mouse model recapitulates genome and transcriptome alterations in human colorectal carcinomas.
    McNeil NE; Padilla-Nash HM; Buishand FO; Hue Y; Ried T
    Genes Chromosomes Cancer; 2017 Mar; 56(3):199-213. PubMed ID: 27750367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current Update of Patient-Derived Xenograft Model for Translational Breast Cancer Research.
    Kawaguchi T; Foster BA; Young J; Takabe K
    J Mammary Gland Biol Neoplasia; 2017 Jun; 22(2):131-139. PubMed ID: 28451789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient-Derived Xenograft Models of Colorectal Cancer: Procedures for Engraftment and Propagation.
    Burgenske DM; Monsma DJ; MacKeigan JP
    Methods Mol Biol; 2018; 1765():307-314. PubMed ID: 29589317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast tumor PDXs are genetically plastic and correspond to a subset of aggressive cancers prone to relapse.
    du Manoir S; Orsetti B; Bras-Gonçalves R; Nguyen TT; Lasorsa L; Boissière F; Massemin B; Colombo PE; Bibeau F; Jacot W; Theillet C
    Mol Oncol; 2014 Mar; 8(2):431-43. PubMed ID: 24394560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PDXliver: a database of liver cancer patient derived xenograft mouse models.
    He S; Hu B; Li C; Lin P; Tang WG; Sun YF; Feng FY; Guo W; Li J; Xu Y; Yao QL; Zhang X; Qiu SJ; Zhou J; Fan J; Li YX; Li H; Yang XR
    BMC Cancer; 2018 May; 18(1):550. PubMed ID: 29743053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishing a human renal cell carcinoma tumorgraft platform for preclinical drug testing.
    Pavía-Jiménez A; Tcheuyap VT; Brugarolas J
    Nat Protoc; 2014 Aug; 9(8):1848-59. PubMed ID: 25010905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.
    Townsend EC; Murakami MA; Christodoulou A; Christie AL; Köster J; DeSouza TA; Morgan EA; Kallgren SP; Liu H; Wu SC; Plana O; Montero J; Stevenson KE; Rao P; Vadhi R; Andreeff M; Armand P; Ballen KK; Barzaghi-Rinaudo P; Cahill S; Clark RA; Cooke VG; Davids MS; DeAngelo DJ; Dorfman DM; Eaton H; Ebert BL; Etchin J; Firestone B; Fisher DC; Freedman AS; Galinsky IA; Gao H; Garcia JS; Garnache-Ottou F; Graubert TA; Gutierrez A; Halilovic E; Harris MH; Herbert ZT; Horwitz SM; Inghirami G; Intlekofer AM; Ito M; Izraeli S; Jacobsen ED; Jacobson CA; Jeay S; Jeremias I; Kelliher MA; Koch R; Konopleva M; Kopp N; Kornblau SM; Kung AL; Kupper TS; LeBoeuf NR; LaCasce AS; Lees E; Li LS; Look AT; Murakami M; Muschen M; Neuberg D; Ng SY; Odejide OO; Orkin SH; Paquette RR; Place AE; Roderick JE; Ryan JA; Sallan SE; Shoji B; Silverman LB; Soiffer RJ; Steensma DP; Stegmaier K; Stone RM; Tamburini J; Thorner AR; van Hummelen P; Wadleigh M; Wiesmann M; Weng AP; Wuerthner JU; Williams DA; Wollison BM; Lane AA; Letai A; Bertagnolli MM; Ritz J; Brown M; Long H; Aster JC; Shipp MA; Griffin JD; Weinstock DM
    Cancer Cell; 2016 Apr; 29(4):574-586. PubMed ID: 27070704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient-derived mouse xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management.
    Nicolle D; Fabre M; Simon-Coma M; Gorse A; Kappler R; Nonell L; Mallo M; Haidar H; Déas O; Mussini C; Guettier C; Redon MJ; Brugières L; Ghigna MR; Fadel E; Galmiche-Rolland L; Chardot C; Judde JG; Armengol C; Branchereau S; Cairo S
    Hepatology; 2016 Oct; 64(4):1121-35. PubMed ID: 27115099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.